Skip to main navigation
Skip to search
Skip to main content
Erasmus University Rotterdam Home
Help & FAQ
Home
Research output
Researchers
Research units
Activities
Prizes
Press/Media
Datasets
Search by expertise, name or affiliation
View Scopus Profile
dr. Wim Dik
Erasmus MC
,
Internal Medicine
Researcher
,
Erasmus MC
,
Immunology
https://orcid.org/0000-0001-5235-3156
Overview
Fingerprint
Network
Research output
(226)
Similar Profiles
(11)
Supervised Work
(11)
Fingerprint
Dive into the research topics where Wim Dik is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Immunology and Microbiology
Immune Response
100%
COVID-19
88%
T Cell
86%
Sarcoidosis
67%
Uveitis
58%
Systemic Lupus Erythematosus
53%
Interferon Type I
50%
Severe Acute Respiratory Syndrome Coronavirus 2
49%
Blood Plasma
44%
Cytokine
44%
Leukocyte
42%
Interleukin 6
39%
Autoantibodies
38%
T Cell Receptor
37%
Gene Expression
33%
Tumor Necrosis Factor
32%
Macrophage
30%
Glucocorticoid
30%
T Helper Cell
28%
Homeobox
27%
Adeno Associated Virus 2
27%
Mastocytosis
27%
Mast Cell
27%
Body Mass
27%
Immunoassay
27%
Proteomics
22%
CD14
21%
HLA-DR
21%
Upregulation
21%
Multiple Sclerosis
20%
Cortisol
20%
Graves' Ophthalmopathy
20%
CD4
18%
Precursor
18%
Angiogenesis
17%
Liquid Chromatography Mass Spectrometry
17%
Antibody Response
17%
Granuloma
17%
Immune System
16%
Interferon Gamma
16%
Cytotoxic T-Cell
16%
Inflammation Response
16%
Immunogenetics
15%
CD16
15%
Intravenous Immunoglobulin
14%
Bioinformatics
14%
B Cell
14%
Innate Lymphoid Cell
14%
Receptor Antibody
14%
down Regulation
14%
Medicine and Dentistry
Ocular Tuberculosis
58%
Diseases
50%
Sarcoidosis
41%
Uveitis
37%
T Lymphocyte Receptor
36%
In Vitro
36%
T Cell
36%
Interferon Type I
35%
Immune Response
31%
Infection
31%
Interferon
29%
Randomized Controlled Trial
29%
Rheumatic Disease
27%
Musculoskeletal Disease
27%
Homeobox
27%
Acute Lymphoblastic Leukemia
27%
Complex Regional Pain Syndrome
27%
Observational Study
27%
Adeno Associated Virus 2
27%
Severe Combined Immunodeficiency
27%
Newborn Screening
27%
Blood Brain Barrier
27%
Cancer Cell
27%
Breast Cancer
27%
Pediatrics
27%
T Lymphocyte
25%
Bacterial Infection
25%
Pathogen
24%
Messenger RNA
23%
Leukocyte
21%
Mast Cell
21%
Serositis
21%
Systematic Review
20%
Prospective Cohort Study
20%
Clinical Feature
20%
Cortisone
19%
Hydrocortisone
19%
Autoantibodies
18%
Interleukin 6
18%
Retinal Vasculitis
17%
COVID-19
17%
Peripheral Blood Mononuclear Cell
17%
Cytokine
17%
Systemic Lupus Erythematosus
17%
Vascularity
16%
Cohort Analysis
16%
Glucocorticoid
16%
Disintegrin
16%
Cardiovascular Disease
16%
Metalloproteinase
16%
Pharmacology, Toxicology and Pharmaceutical Science
Diseases
92%
Inflammation
62%
Ocular Tuberculosis
58%
Syndrome
43%
Interferon
40%
Infection
39%
Uveitis
39%
Biological Marker
35%
Non Insulin Dependent Diabetes Mellitus
30%
Sarcoidosis
28%
Rheumatic Disease
27%
Musculoskeletal Disease
27%
Endocrine Ophthalmopathy
27%
Tumor Necrosis Factor
26%
Clinical Feature
22%
Platelet Derived Growth Factor BB
22%
Cytokine
22%
Interferon Type I
21%
Disease Activity
20%
Neoplasm
20%
Bacterial Infection
18%
Interleukin 6
18%
Prospective Cohort Study
17%
Systemic Lupus Erythematosus
17%
Soluble Interleukin 2 Receptor
16%
Immunosuppressive Agent
15%
Cardiovascular Disease
15%
Sepsis
15%
Anti-Inflammatory Drug
15%
Randomized Controlled Trial
14%
Disease Severity
14%
Complex Regional Pain Syndrome
13%
Hemophagocytic Syndrome
13%
Metalloproteinase
13%
Adeno Associated Virus 2
13%
Oxylipin
13%
Clinical Research
13%
Diabetic Retinopathy
13%
Observational Study
13%
STAT Protein
13%
Liver Fibrosis
13%
Disintegrin
13%
Severe Combined Immunodeficiency
13%
Brain Metastasis
13%
Chorionic Gonadotropin
13%
Thrombospondin
13%
Mycophenolate Mofetil
13%
Bosentan
13%
Immunomodulating Agent
13%
Comorbidity
13%
